A cannabinoids company backed by David Beckham become the first company of its kind to formally unveil plans for a main London stock market debut.

Cellular Goods, a UK-based provider of premium consumer products based on biosynthetic cannabinoids.

More than 6,000 valid applications for shares were received in respect of the IPO. 

Cellular Goods is the first provider of premium consumer products based on biosynthetic cannabinoids to join the London stock market.

The company, which is run by Alexis Abraham (https://news.sky.com/story/beckham-backed-cannabis-venture-becomes-first-to-score-with-london-float-12207613) , has sold a minority stake to DB Ventures, the former Manchester United and England midfielder's global brand management and commercial ventures arm, according to people close to the situation.

Commenting on Cellular Goods' flotation, Alexis Abraham, Chief Executive Officer, said, " Cellular Goods' debut on the London Stock Exchange is a major step in the Company's development and provides a strong foundation to execute our long-term growth strategy. We are delighted with the strong support from a wide range of institutional and retail investors to build premium consumer products based on biosynthetic cannabinoids under the Cellular Goods brand."

https://www.share-talk.com/alexis-abraham-ceo-of-cellular-goods-plc-cbx-l-interview/

Show Notes

A cannabinoids company backed by David Beckham become the first company of its kind to formally unveil plans for a main London stock market debut.


Cellular Goods, a UK-based provider of premium consumer products based on biosynthetic cannabinoids.


More than 6,000 valid applications for shares were received in respect of the IPO. 


Cellular Goods is the first provider of premium consumer products based on biosynthetic cannabinoids to join the London stock market.


The company, which is run by Alexis Abraham, has sold a minority stake to DB Ventures, the former Manchester United and England midfielder's global brand management and commercial ventures arm, according to people close to the situation.



Commenting on Cellular Goods' flotation, Alexis Abraham, Chief Executive Officer, said, " Cellular Goods' debut on the London Stock Exchange is a major step in the Company's development and provides a strong foundation to execute our long-term growth strategy. We are delighted with the strong support from a wide range of institutional and retail investors to build premium consumer products based on biosynthetic cannabinoids under the Cellular Goods brand."

https://www.share-talk.com/alexis-abraham-ceo-of-cellular-goods-plc-cbx-l-interview/

Listen On

Also Listen